MCL1 and B-cell chronic lymphocytic leukemia: In previous studies, we found that treating CLL cells with the PIM kinase inhibitor SGI-1776 inhibited downstream PIM kinase substrates and affected the MCL-1 protein, which may cause drug-induced apoptosis [7].